Pay in 4 interest-free payments of $7.45 Learn more
Ships within 48 hours · Estimated delivery Sep 3 - Sep 8
- Protect from light and moisture
Retatrutide is an investigational peptide drug currently under clinical development by Eli Lilly
Fat-loss and metabolic compound comparison Compound 5-Amino-1MQ Mechanism NNMT inhibitor
Scientific References Triple-Hormone-Receptor Agonist Retatrutide for Obesity - A Phase 2 Trial
Both cardiovascular exercise and resistance training support AOD-9604 protocols, though through different mechanisms
Why Perfect B Is Evaluating AOD 9604: Our Clinical Perspective We began our internal evaluation of AOD 9604 in response to a consistent pattern we were seeing with patients in our South Florida practice: people who had experienced meaningful fat loss on GLP-1 medications, then plateaued or discontinued due to side effects, and were looking for a next option
US$ 21.75
US$ 23.77
US$ 25.16
US$ 22.55
US$ 21.95
US$ 29.87
US$ 24.95
